Evidence map›Paper›PMID 19578996›Full record

ArticleClinical reviews in allergy & immunology2010

Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria.

Manuel Ramos-Casals, Pilar Brito-Zerón, Marta Perez-De-Lis, Iratxe Jimenez, Maria-Jose Blanco, Albert Bove, Maria-Jose Soto, Miriam Akasbi, Candido Diaz, Juan Sentís and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical reviews in allergy & immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Update on Sjögren Syndrome and Other Causes of Sicca in Older Adults.Rheumatic diseases clinics of North America · 2018
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. The future of autoimmunity.Clinical reviews in allergy & immunology · 2012
    Article
  14. Cutting-edge issues in organ-specific autoimmunity.Clinical reviews in allergy & immunology · 2011
    Article
  15. Article
  16. [Pathogenesis and diagnosis of Sjögren's syndrome].Zeitschrift fur Rheumatologie · 2010
    Review
  17. [Epidemiology of primary Sjörgren's syndrome].Zeitschrift fur Rheumatologie · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Manuel Ramos-CasalsDepartment of Autoimmune Diseases, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Barcelona, Spain. mramos@clinic.ub.es
Pilar Brito-Zerón
Marta Perez-De-Lis
Iratxe Jimenez
Maria-Jose Blanco
Albert Bove
Maria-Jose Soto
Miriam Akasbi
Candido Diaz
Juan Sentís
Antoni Siso
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESConsorci d’Atenció Primària de Salut Barcelona Esquerra · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current 2002 classification criteria do not cover the broad clinical and immunological heterogeneity of primary Sjögren syndrome (SS), since five of the six criteria focus exclusively on glandular involvement and the remaining criterion is the mandatory presence of anti-Ro/La antibodies. The aim of this study was to analyze the clinical features of patients with a well-established diagnosis of primary SS who do not fulfill the 2002 classification criteria. Five hundred seven patients diagnosed with primary SS (1993 criteria) were consecutively included and followed up. Two hundred twenty-one (44%) patients did not fulfill the 2002 criteria. These patients were older at diagnosis (p < 0.001) and had a lower frequency of parotid enlargement (p = 0.002), fever (p = 0.041), arthritis (p = 0.041), vasculitis (p = 0.050), peripheral neuropathy (p = 0.002), cranial nerve involvement (p = 0.015), raised erythrocyte sedimentation rate ( ESR) levels (p < 0.001), anemia (p < 0.001), leukopenia (p = 0.037), hypergammaglobulinemia (p < 0.001), positive rheumatoid factor ( RF; p = 0.002), and cryoglobulinemia (p = 0.049) in comparison with those fulfilling 2002 criteria. However, there were no significant differences in the prevalence of sicca features, diagnostic tests, overall systemic involvement, antinuclear antibodies , complement levels, development of B-cell lymphoma, or survival. Patients with anti-Ro antibodies had the highest frequencies of systemic features, hematological abnormalities, and altered immunological markers. In conclusion, patients fulfilling the 2002 criteria, who have either a specific histological diagnosis (lymphocytic infiltration) or highly specific autoantibodies (Ro/La), might well be considered to have Sjögren "disease." In contrast, etiopathogenic mechanisms other than lymphocytic-mediated epithelial damage could be involved in patients with negative Ro and negative biopsy, in whom the term Sjögren "syndrome" seems more adequate.

Indexed as

Practice Guidelines as TopicAntibodies, AntinuclearAutoantibodiesFemaleHumansMaleMiddle AgedSjogren's SyndromeAntibodies, AntinuclearAutoantibodiesSS-A antibodies

Identifiers

PMID19578996
OpenAlexW1982007263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.